Probiotic supplements have become the fastest-growing supplement products on the market, and consumers are paying more attention to their guts than ever. Yet the tools they reach for may not do what they expect. A 2026 study in Clinical Gastroenterology and Hepatology by Nutrition Insight shows that use of probiotic supplements jumped 287% among US adults and 786% among people under 20 between 2009 and 2023, even as consumption of microbiome-supporting foods barely changed. The American Cancer Society notes that colorectal cancer is expected to claim about 55,230 lives in the United States in 2026, with incidence rising in people aged 20 to 49.
The probiotic story has had huge interest for about 25 years. Since the first probiotics reached consumer shelves around the year 2000, the message has been simple. Take good bacteria to crowd out the bad. But the science has become more complicated. Probiotics do attach to the gut as transient visitors, yet research from Oxford Academic suggests that incoming probiotics face strong colonization resistance. The bad bacteria can stay colonized, and the rebalancing usually does not happen on its own.
